ERK Inhibitor JSI-1187 in Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
A Phase 1/2 Study of KSQ-001EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate the SOCS1 Gene, in Patients With Select Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Leflunomide or Combination of MEK Inhibitor and Hydroxychloroquine for Refractory Patients With RAS Mutations
- Status
- RECRUITING
- Phase
- PHASE2
AI-based Medical Device Validation for Early Melanoma Detection
- Status
- COMPLETED
- Phase
- N/A
RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node Metastasis
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Allogeneic Gammadelta T Cells Combined With Interferon-α1b or PD-1 Monoclonal Antibody in Stage III-IV Amenable to Surgical Resection Melanoma
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
Quantitative Analysis of PET/CT Images of Immune Related Side Effects in Metastatic Melanoma Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
To Evaluate the Safety and Efficacy of ADP-TILIL7 in Patients With Locally Advanced or Metastatic Melanoma
- Status
- RECRUITING
- Phase
- PHASE1
Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients
- Status
- RECRUITING
- Phase
- N/A
A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better Than Anti-PD1 Alone in Adult Participants With Resectable Stage 3 or 4 Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Holistic Needs Assessments in Patients With Melanoma
- Status
- COMPLETED
- Phase
- N/A
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2
Mind Over Matter for Black and African American Women: A Single Arm Trial Examining Feasibility and Acceptability of a Supportive Intervention
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate Treatment With Nivolumab Alone and Nivolumab Combined With Ipilimumab in Children With Melanoma
- Status
- COMPLETED
- Phase
- N/A
Profiling of Circulating Immune Cells to Uncover Response Signatures to Anti-PD1 Immunotherapy in Melanoma Patients
- Status
- RECRUITING
- Phase
- N/A
A PK Study to Compare GME751 (Proposed Pembrolizumab Biosimilar) and US-licensed and EU-authorized Keytruda® in Participants With Stage II and III Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Use of Serial Plasma NGS as a New Efficacy Metric to Guide Immunotherapy Treatment Discontinuation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
A Study of GC101 TIL in Advanced Melanoma (BZ)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Nivolumab Dose Optimization in Patients With a Complete, Partial or Stable Response
- Status
- RECRUITING
- Phase
- PHASE4
A Study to Evaluate Whether Participants With Melanoma Prefer Subcutaneous vs Intravenous Administration of Nivolumab and Nivolumab + Relatlimab Fixed-dose Combinations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2